Fidson Healthcare Plc: Backed by Strong Financial Growth

[Chinyere]

Fidson Healthcare Plc is not just a “future play”—the numbers already show serious momentum.
Key Financials (FY 2025):
Revenue: ~₦119 billion (+41% YoY)
Profit Before Tax: ~₦13.8 billion (+~61% YoY)
Net Income: ~₦9.3 billion
Gross Profit: ~₦49.1 billion (strong margin expansion)
EPS: ~₦3.88 (up from ~₦2.52)
Growth Trend (9M 2025):
Revenue: ₦93.1 billion (+56%)
Profit: ₦8 billion (+132%)

What This Means
This is not just a narrative stock → earnings are already growing fast
Strong top-line + profit expansion = real execution
High P/E is justified by high growth rate (30%+ earnings growth)
Real Insight
Fidson is a growth + execution story, not just speculation.
But…

The market already expects a lot from it.
So the play is:
Enter on dips (like post-dividend)
Hold for earnings compounding

With this level of growth already priced in, do you think Fidson still has room to outperform, or is the market getting ahead of its fundamentals?

 

[John Esther]

Fidson Healthcare Plc is not just a “future play”—the numbers already show serious momentum.
Key Financials (FY 2025):
Revenue: ~₦119 billion (+41% YoY)
Profit Before Tax: ~₦13.8 billion (+~61% YoY)
Net Income: ~₦9.3 billion
Gross Profit: ~₦49.1 billion (strong margin expansion)
EPS: ~₦3.88 (up from ~₦2.52)
Growth Trend (9M 2025):
Revenue: ₦93.1 billion (+56%)
Profit: ₦8 billion (+132%)

What This Means
This is not just a narrative stock → earnings are already growing fast
Strong top-line + profit expansion = real execution
High P/E is justified by high growth rate (30%+ earnings growth)
Real Insight
Fidson is a growth + execution story, not just speculation.
But…

The market already expects a lot from it.
So the play is:
Enter on dips (like post-dividend)
Hold for earnings compounding

With this level of growth already priced in, do you think Fidson still has room to outperform, or is the market getting ahead of its fundamentals?

Fidson is clearly delivering real growth, not just hype, but the market has already priced in a lot of that momentum. It can still outperform if earnings keep beating expectations, but at this point, timing matters, buying on dips and letting the growth compound is the smarter approach.

 

[Chinyere]

Fidson is clearly delivering real growth, not just hype, but the market has already priced in a lot of that momentum. It can still outperform if earnings keep beating expectations, but at this point, timing matters, buying on dips and letting the growth compound is the smarter approach.

Fidson’s growth is tangible, but much is already reflected in the price. Smart entry on dips and patience to let earnings compound will maximize returns over time.